1. Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma
    DengYong Zhang et al, 2023, Scientific Reports CrossRef
  2. A systematic approach to prioritize drug targets using machine learning, a molecular descriptor-based classification model, and high-throughput screening of plant derived molecules: a case study in oral cancer
    Vinay Randhawa et al, 2015, Molecular BioSystems CrossRef
  3. Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma
    Yi-Ru Pan et al, 2022, Frontiers in Immunology CrossRef
  4. WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
    Luke Boulter et al, 2015, Journal of Clinical Investigation CrossRef
  5. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma
    Brian K. Chung et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  6. Synthesis and Biological Evaluation of an 18Fluorine-Labeled COX Inhibitor—[18F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors
    Ying-Cheng Huang et al, 2016, Molecules CrossRef
  7. Overexpression of PDZK1IP1, EEF1A2 and RPL41 genes in intrahepatic cholangiocarcinoma
    GUANGHUA YANG et al, 2016, Molecular Medicine Reports CrossRef
  8. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets
    Q-X Huang et al, 2016, Cancer Gene Therapy CrossRef
  9. Biomarker Identification for Liver Hepatocellular Carcinoma and Cholangiocarcinoma Based on Gene Regulatory Network Analysis
    Qiuyan Huo et al, 2021, Current Bioinformatics CrossRef